New Zealand markets open in 9 hours 14 minutes

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1709-0.0091 (-5.06%)
At close: 04:00PM EDT
0.1788 +0.01 (+4.62%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.1800
Bid0.1750 x 4000
Ask0.1713 x 1100
Day's range0.1700 - 0.1862
52-week range0.1700 - 1.1100
Avg. volume852,850
Market cap21.408M
Beta (5Y monthly)1.98
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer

    Industry veteran brings extensive experience in the development and commercialization of advanced biological therapies, including in the field of complement (C5)NEW YORK and LONDON, March 02, 2022 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LBT4) systems are implicated, today announced the appointment of Rachelle

  • GlobeNewswire

    uniQure Announces the Appointment of Rachelle Jacques to its Board of Directors

    Biotech Executive Brings Extensive Experience Developing Advanced Therapies and Regenerative Medicines Rachelle Jacques Newly elected uniQure board member, Rachelle Jacques LEXINGTON, Mass. and AMSTERDAM, Oct. 21, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the appointment of Rachelle Jacques to its Board of Directors. Ms. Jacques, who will serve on the Board’s Audi